ILYANG PHARMACEUTICAL CO.,LTD

Highlights Ilyang Pharmaceutical Co.,Ltd

Equities

A007570

KR7007570005

End-of-day quote Korea S.E. Other stock markets 23:00:00 30/06/2024 BST			5-day change	1st Jan Change
13,000 ^KRW	+1.72%		+0.70%	-16.93%

2023	Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 6, 2023.	CI
2023	Ilyang Pharmaceutical Co.,Ltd's Equity Buyback announced on April 6, 2023, has expired with 115,080 shares, representing 0.63% for KRW 1,999.72 million.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 6, 2023.	10/10/23	CI
Ilyang Pharmaceutical Co.,Ltd's Equity Buyback announced on April 6, 2023, has expired with 115,080 shares, representing 0.63% for KRW 1,999.72 million.	09/10/23	CI
Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 6, 2023.	13/07/23	CI
Ilyang Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Ilyang Pharmaceutical Co.,Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.	06/04/23	CI
Ilyang Pharmaceutical Co.,Ltd authorizes a Buyback Plan.	05/04/23	CI
Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on March 10, 2022.	08/09/22	CI
Ilyang Pharmaceutical Co.,Ltd's Equity Buyback announced on March 10, 2022, has expired with 118,321 shares, representing 0.65% for KRW 2,859.89 million.	07/09/22	CI
Ilyang Pharmaceutical Co.,Ltd announces an Equity Buyback for KRW 3,000 million worth of its shares.	10/03/22	CI
Ilyang Pharmaceutical Co.,Ltd authorizes a Buyback Plan.	09/03/22	CI
Il-Yang Pharmaceutical Signs Licence with Laboratorios Biopas to Export Leukemia Drug Supect to Colombia	05/09/16	CI
Ilyang Pharmaceutical Co., Ltd's Equity Buyback Plan Extended till September 25, 2022.	18/09/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer